Prolinex takes an entirely new approach to food supplements. Applying cutting-edge metabolic profiling to a wide range of diseases, Prolinex have identified a range of metabolic deficiences associated with prevalent diseases such as osteoporosis, rheumatoid arthritis and heart disease. The result is a range of entirely novel food supplement products which are currently undergoing rigorous testing for safety and efficacy. Prolinex is the first company worldwide to apply the same scientific standards to support the launch of food supplements as are required for drugs.
During 2009, Prolinex Ltd was acquired by Total Scientific, a leader in metabolite profiling services and biomarker discovery. This combination will unlock the potential in the Prolinex business model, and deliver high value products into the market place.